微芯生物
(688321)
| 流通市值：125.81亿 | | | 总市值：136.65亿 |
| 流通股本：4.08亿 | | | 总股本：4.43亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 257,038,676.31 | 910,061,840.72 | 674,157,709.09 | 406,598,517.7 |
| 营业总成本 | 224,552,523.96 | 846,023,589.62 | 597,523,641.23 | 376,480,827.83 |
| 其他经营收益 | | | | |
| 营业利润 | 28,896,419.94 | 50,111,980.97 | 70,399,030.3 | 28,120,919.48 |
| 利润总额 | 28,652,328.91 | 50,052,450.53 | 70,314,760.35 | 28,065,637.36 |
| 净利润 | 28,271,869.04 | 50,959,162.56 | 70,767,514.85 | 29,592,228.83 |
| 每股收益 | | | | |
| 其他综合收益 | -673,116.67 | -972,852.61 | -516,553.25 | -209,350.4 |
| 综合收益总额 | 27,598,752.37 | 49,986,309.95 | 70,250,961.6 | 29,382,878.43 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,064,481,235.6 | 1,180,388,674.71 | 1,338,524,487.15 | 1,246,399,390.82 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,517,451,590.7 | 2,470,107,721.12 | 2,294,668,340.76 | 2,188,403,802.3 |
| 资产总计 | 4,581,932,826.3 | 3,650,496,395.83 | 3,633,192,827.91 | 3,434,803,193.12 |
| 流动负债: | | | | |
| 流动负债合计 | 805,157,918.65 | 843,902,453.31 | 716,038,451.58 | 650,505,729.15 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,192,189,750.85 | 1,180,769,878.5 | 1,261,270,465.27 | 1,169,543,706.34 |
| 负债合计 | 1,997,347,669.5 | 2,024,672,331.81 | 1,977,308,916.85 | 1,820,049,435.49 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,584,585,156.8 | 1,625,824,064.02 | 1,655,883,911.06 | 1,614,753,757.63 |
| 股东权益合计 | 2,584,585,156.8 | 1,625,824,064.02 | 1,655,883,911.06 | 1,614,753,757.63 |
| 负债和股东权益合计 | 4,581,932,826.3 | 3,650,496,395.83 | 3,633,192,827.91 | 3,434,803,193.12 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 270,052,993.79 | 878,200,278.36 | 637,831,624.93 | 433,184,403.84 |
| 经营活动现金流出小计 | 245,709,035.68 | 781,234,920.07 | 577,909,550.15 | 371,125,906.32 |
| 经营活动产生的现金流量净额 | 24,343,958.11 | 96,965,358.29 | 59,922,074.78 | 62,058,497.52 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 310,160,743.12 | 1,667,499,604.24 | 1,110,864,563.78 | 696,041,367.29 |
| 投资活动现金流出小计 | 1,004,357,608.99 | 1,885,115,121.58 | 1,259,808,047.82 | 745,964,987.8 |
| 投资活动产生的现金流量净额 | -694,196,865.87 | -217,615,517.34 | -148,943,484.04 | -49,923,620.51 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,048,863,997.44 | 491,902,465 | 401,885,265 | 197,000,000 |
| 筹资活动现金流出小计 | 135,646,418.42 | 364,302,314.7 | 237,912,188.88 | 102,310,830.17 |
| 筹资活动产生的现金流量净额 | 913,217,579.02 | 127,600,150.3 | 163,973,076.12 | 94,689,169.83 |
| 汇率变动对现金及现金等价物的影响 | -788,180.1 | -807,474.93 | -1,729,409.36 | -77,413.06 |
| 现金及现金等价物净增加额 | 242,576,491.16 | 6,142,516.32 | 73,222,257.5 | 106,746,633.78 |
| 期末现金及现金等价物余额 | 471,259,416.34 | 228,682,925.18 | 295,762,666.36 | 329,287,042.64 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 6,142,516.32 | - | 106,746,633.78 |
最新报告期：2026-07-21| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 财通证券 | 华挺 | 0.25 | 0.43 | 0.65 | 2026-07-21 |